There are 2137 resources available
465P - Single nucleotide polymorphism (SNP) analysis identifies potential prognostic and predictive biomarker in patients (pts) with metastatic colorectal cancer (mCRC) treated with regorafenib in the phase III CORRECT trial
Presenter: Francesca Battaglin
Session: E-Poster Display
Resources:
Abstract
466P - FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis
Presenter: Mikhail Fedyanin
Session: E-Poster Display
Resources:
Abstract
468P - PANIB 20139173: Randomized, multicentre phase II trial comparing fluorouracil, leucovorin and oxaliplatin (FOLFOX) plus panitumumab versus FOLFOX plus bevacizumab in patients with previously untreated, RAS wild-type (WT) metastatic colorectal cancer (mCRC)
Presenter: Kathleen Janssens
Session: E-Poster Display
Resources:
Abstract
469P - Efficacy and safety of anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer - A single-arm, multi-center, phase II study (ALTER-C-002 trial)
Presenter: Kefeng Ding
Session: E-Poster Display
Resources:
Abstract
470P - Anti-tumor mechanisms of rigosertib in colorectal cancer
Presenter: Seyed Mahdi Hassanian Mehr
Session: E-Poster Display
Resources:
Abstract
471P - Identification and validation of a new prognostic score in metastatic colorectal cancer (mCRC): GEMCAD score
Presenter: Elia Seguí
Session: E-Poster Display
Resources:
Abstract
472P - Whole genome sequencing of metastatic CRC reveals footprints from the past and present with future clinical relevance
Presenter: Pauline Mendelaar
Session: E-Poster Display
Resources:
Abstract
473P - PLK1 expression and KRAS mutations in colorectal cancer
Presenter: Priya Jayachandran
Session: E-Poster Display
Resources:
Abstract
474P - Prognostic and predictive role of Consensus Molecular Subtypes (CMS) determined by immunohistochemistry in metastatic colorectal cancer (mCRC)
Presenter: Oliver Higuera Gomez
Session: E-Poster Display
Resources:
Abstract
475P - Diffusion kurtosis imaging signature in predicting the chemotherapeutic response of colorectal liver metastases: The result of the FDZL-MRinCLM study
Presenter: Wenhua Li
Session: E-Poster Display
Resources:
Abstract